SHOPPING CART
REGISTER
LOGIN
SEARCH

Diagnostic Testing & Technology Report

February 2010

IVD Stocks Rose 31% in 2009 Led by Inverness, Clinical Data, Affy

The 16 stocks in the G-2 Diagnostic Stock Index climbed an unweighted average of 31 percent in 2009 versus respective gains of 44 percent and 23 percent for the Nasdaq and the S&P 500.

Login | Subscribe

February 2010 - Table of Contents

DTTR February 2010 (Full PDF Issue)

Genomic Health Revenue Climbs 35% in 2009

Quidel to Acquire Diagnostic Hybrids for $130M

Predictive Biosciences Buys CLIA-Certified Anatomic Pathology Lab

ADA Issues Updated Recommendations for Diabetes Testing

Cepheid Receives FDA Emergency Use Authorization for H1N1 Flu Test

Philips and bioMerieux to Jointly Develop Point-of-Care Tests

Abbott Receives CE Mark for Ovarian Cancer Test

Inside the Diagnostic Industry: Genomic Health Looks to Replicate Its Oncotype DX Across Multiple Cancers, Continents

Seeing Strong Growth in Clinical Applications, Life Technologies Expands Molecular Diagnostics Franchise

Quest Diagnostics Introduces Lab-Developed Test for Colorectal Cancer

Genetic Variant Linked to Aggressive Form of Prostate Cancer

New Payers Sign On to McKesson�s Molecular Dx Criteria Analysis System

Medicare Spending Up, Even as National Health Spending Slows

IVD Stocks Rose 31% in 2009 Led by Inverness, Clinical Data, Affy

G2 Insider (February 2010)

Diagnostic Testing & Technology Report is part of...

Focus Areas	Product Group
G2 Reports Medical Lab Management	Newsletters